This page contains a Flash digital edition of a book.
The Challenge of Mediastinal Staging


in staging lung cancer: how does it change the algorithm?, Lung Cancer, 2004;44:175–81.


18. Cerfolio RJ, Bryant AS, Eloubeidi MA, Routine mediastinoscopy and esophageal ultrasound fine-needle aspiration in patients with non-small cell lung cancer who are clinically N2 negative, Chest, 2006;130:1791–5.


19. Maedaa R, Isowaa N, Onumab N, et al., The maximum standardized 18F-fluorodeoxyglucose uptake on positron emission tomography predicts lymph node metastasis and invasiveness in clinical stage IA non-small cell lung cancer, Interact Cardiovasc Thorac Surg, 2009;9:79–82.


20. De Wever W, Stroobants S, Coolen J, Verschakelen JA, Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration, Eur Respir J, 2009;33:201–12.


21. Harrow EM, Abi-Saleh W, Blum J, et al., The utility of transbronchial needle aspiration in the staging of bronchogenic carcinoma, Am J Respir Crit Care Med, 2000;161:601–7.


22. Toloza EM, Harpole L, Detterbeck F, McCrory DC, Invasive staging of non-small cell lung cancer, Chest, 2003;123: 157S–166S.


23. Baram D, Garcia RB, Richman PS, Impact of rapid on-site cytologic evaluation during transbronchial needle aspiration, Chest, 2005;128:869–75.


24. Davenport RD, Rapid on-site evaluation of transbronchial aspirates, Chest, 1990;98:59–61.


25. Diacon AH, Schuurmans MM, Theron J, et al., Utility of rapid on-site evaluation of transbronchial needle aspirates, Respiration, 2005;72:182–8.


26. Herth F, Becker HD, Ernst A, Ultrasound-guided transbronchial needle aspiration. An experience in 242 patients, Chest, 2003;123:604–7.


27. Silvestri GA, Hoffman BJ, Bhutani MS, et al., Endoscopic ultrasound with fine-needle aspiration in the diagnosis and staging of lung cancer, Ann Thorac Surg, 1996;61:1441–5.


28. Herth F, Becker HD, Ernst A, Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration, Chest, 2004;125:322–5.


29. Herth FJ, Eberhardt R, Vilmann P, et al., Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes, Thorax, 2006;61:795–8.


30. Trisolini R, Lazzari Agli L, Patelli M, Conventional vs endobronchial ultrasound-guided transbronchial needle aspiration of the mediastinum, Chest, 2004;126;1005–6.


31. Shannon JJ, Bude RO, Orens JB, et al., Endobronchial ultrasound-guided needle aspiration of mediastinal adenopathy, Am J Respir Crit Care Med, 1996;153:1424–30.


32. Fritscher-Ravens A, Endoscopic ultrasound evaluation in the diagnosis and staging of lung cancer, Lung Cancer, 2003;41: 259–67.


33. Micames CG, McCrory DC, Pavey DA, et al., Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging, Chest, 2007;131;539–48.


34. Vilmann P, Larsen SS, Endoscopic ultrasound-guided biopsy in the chest: little to lose, much to gain, Eur Respir J, 2005;25:400–1.


35. Szlubowski A, Kuzdzał J, Kołodziej M, et al., Endobronchial ultrasound-guided needle aspiration in the non-small cell lung cancer staging, Eur J Cardiothorac Surg, 2009;35:332–6.


36. Martínez-Olondris PP, Molina-Molina M, Xaubet A, et al., Punción transbronquial aspirativa en el estudio de las adenopatías mediastínicas: rentabilidad y coste-beneficio,


Arch Bronconeumol, 2008;44:290–94.


37. Alsharif M, Andrade RS, Groth SS, et al., Endobronchial ultrasound-guided transbronchial fine-needle aspiration, Am J Clin Pathol, 2008;130:434–43.


38. Karfis EA, Roustanis E, Beis J, Kakadellis J, Video-assisted cervical mediastinoscopy: our seven-year experience, Interact Cardiovasc Thorac Surg, 2008;7:1015–8.


39. Lemaire A, Nikolic I, Petersen T, et al., Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate, Ann Thorac Surg, 2006;82:1185–9.


40. Call S, Rami-Porta R, Serra-Mitjans M, et al., Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma of the left lung, Eur J Cardiothorac Surg, 2008; 34:1081–4.


41. Ebner H, Marra A, Butturini E, De Santis F, Clinical value of cervical mediastinoscopy in the staging of bronchial carcinoma, Ann Ital Chir, 1999;70:873–9.


42. Little AG, Gay EG, Gaspar LE, Stewart AK, National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care, Lung Cancer, 2007;57:253–60.


43. Vilmann P, Puri R, The complete ‘medical’ mediastinoscopy (EUS-FNA + EBUS-TBNA), Minerva Med, 2007;98:331–8.


44. Wallace MB, Ravenel J, Block MI, et al., Endoscopic ultrasound in lung cancer patients with a normal mediastinum on computed tomography, Ann Thorac Surg, 2004;77:1763–8.


45. Meyers BF, Haddad F, Siegel BA, et al., Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer, J Thorac Cardiovasc Surg, 2006;131:822–9.


46. Hishida T, Problems in the current diagnostic standards of clinical N1 non-small cell lung cancer, Thorax, 2008;63:526–31.


47. Miller DL, Rowland CM, Deschamps C, et al., Surgical treatment of non-small cell lung cancer 1 cm or less in diameter, Ann Thorac Surg, 2002;73:1545–51.


48. Riqueta M, Manac’ha D, Le Pimpec Barthesa F, et al., Prognostic value of T and N in non small cell lung cancer three centimeters or less in diameter, Eur J Cardiothorac Surg, 1997;11:440–4.


49. Nonaka M, Kadokura M, Yamamoto S, et al., Tumor dimension and prognosis in surgically treated lung cancer: for intentional limited resection, Am J Clin Oncol, 2003;26: 499–503.


50. Nirmal K, Veeramachaneni A, Richard J, et al., Risk factors for occult nodal metastasis in clinical T1N0 lung cancer: a negative impact on survival, Eur J Cardiothorac Surg, 2008;33:466–9.


51. Takamochi K, Nagai K, Suzuki K, et al., Clinical predictors of N2 disease in non-small cell lung cancer, Chest, 2000;117: 1577–82.


52. Suzuki K, Nagai K, Yoshida J, et al., Clinical predictors of N2 disease in the setting of negative computed tomographic scan in patients with lung cancer, J Thorac Cardiovasc Surg, 1999;117:593–8.


53. Shafazand S, Gould MK, A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer, J Thorac Oncol, 2006;1:953–9.


54. Downey RJ, Akhurst T, Gonen M, et al., Preoperative F-18 fluorodeoxyglucose–positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection, J Clin Oncol, 2004,22:3255–60.


55. Cerfolio RJ, Bryant AS, Ohja B, Bartolucci AA, The maximum


standardized uptake values on positron emission tomography of a non–small cell lung cancer predict stage, recurrence, and survival, J Thorac Cardiovasc Surg, 2005;130:151–9.


56. Lee PC, Port JL, Korst RJ, et al., Risk factors for occult mediastinal metastases in clinical stage I non-small cell lung cancer, Ann Thorac Surg, 2007;84:177–81.


57. Takizawa T, Terashima M, Koike T, et al., Lymph node metastasis in small peripheral adenocarcinoma of the lung, J Thorac Cardiovasc Surg, 1998;116:276–80.


58. Al-Sarraf N, Aziz R, Gately K, et al., Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography, Eur J Cardiothorac Surg, 2008;33:104–9.


59. Zhoua Q, Suzukia K, Anamia Y, et al., Clinicopathologic features in resected subcentimeter lung cancer – status of lymph node metastases, Interact Cardiovasc Thorac Surg, 2010;10:53–7.


60. Fukui T, Katayama T, Ito S, et al., Clinicopathological features of small-sized non-small cell lung cancer with mediastinal lymph node metastasis, Lung Cancer, 2009;66:309–13.


61. Tournoy KG, van Meerbeeck JP, New American College of Chest Physicians guidelines on mediastinal staging and management of stage IIIA –N2 non-small cell lung cancer: a European perspective, Pol Arch Med Wewn, 2008;118:175–8.


62. Martini N, Flehinger BJ, The role of surgery in N2 lung cancer, Surg Clin North Am, 1987;67:1037–49.


63. Goldstraw P, Mannam GC, Kaplan DK, Michail P, Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease), J Thorac Cardiovasc Surg, 1994;107:19–27.


64. Van Klaveren RJ, Festen J, Otten HJ, et al., Prognosis of unsuspected but completely resectable N2 non-small cell lung cancer, Ann Thorac Surg, 1993;56:300–4.


65. Vansteenkiste JF, De Leyn PR, Deneffe GJ, et al., Survival and prognostic factors in resected N2 non-small cell lung cancer: a study of 140 cases. Leuven Lung Cancer Group, Ann Thorac Surg, 1997;63:1441–50.


66. Okada M, Tsubota N, Yoshimura M, et al., Prognosis of completely resected pN2 non-small cell lung carcinomas: What is the significant node that affects survival?, J Thorac Cardiovasc Surg, 1999;118:270–5.


67. Andre F, Grunenwald D, Pignon JP, et al., Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications, J Clin Oncol, 2000;18:2981–9.


68. De Leyn P, Schoonooghe P, Deneffe G, et al., Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease), Eur J Cardiothorac Surg, 1996;10:649–54, discussion 654–5.


69. Naruke T, Goya T, Tsuchiya R, Suemasu K, The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis, Ann Thorac Surg, 1988;46:603–10.


70. Quint LE, Staging non-small cell lung cancer, Cancer Imaging, 2007;7:148–59.


71. Patel V, Shrager JB, Which patients with stage III non-small cell lung cancer should undergo surgical resection, The Oncologist, 2005;10:335–44.


72. Kelly RF, Tran T, Holmstrom A, et al., Accuracy and cost- effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non- small cell lung cancer, Chest, 2004;125:1413–23.


73. Ceron L, Michieletto L, Zamperlin A, Mediastinal staging in lung cancer: a rational approach, Monaldi Arch Chest Dis, 2009;71:170–5.


EUROPEAN ONCOLOGY & HAEMATOLOGY


35


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92